ABT
Abbott Laboratories
NYQ
$86.97
-0.81
(-0.92%)
Neutral · -0.41σ
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$151.5B
P/E ttm
24.4
Fwd P/E
14.3
Beta
0.65
Day range
$86.97
52w range
$81.97 – $129.64
Avg vol
12.6M
RSI(2)
52.0
ROE
12.3%
Net mgn
13.9%
FCF mgn
14.1%
Debt/Eq
0.65
Div yld
290.00%
Sector
Healthcare
Industry
Medical Devices
Next earn
2026-07-16
Matrix setup grades
Long
—
score 6 · tech 6 / 80 · support 0 / 20
above KC1 lower, -0.33 ATR from EMA21 · no notable pattern
- · Counter-trend long in breakout_down
Short
—
score 16 · tech 16 / 80 · support 0 / 20
below KC1 upper, -0.33 ATR from EMA21 · no notable pattern
- · Aligned with breakout_down (strong tailwind)
Options · swing
See more →
CALL
$90
2026-07-17
$2.98
PUT
$90
2026-07-17
$6.05
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-16
- EPS (act / est)
- 1.15 / 1.15
- Surprise
- +0.3%
- Next report
- 2026-07-16
About
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel synd…